Skip header and navigation

Refine By

17 records – page 1 of 2.

2009 Canadian Cardiovascular Society/Canadian guidelines for the diagnosis and treatment of dyslipidemia and prevention of cardiovascular disease in the adult - 2009 recommendations.

https://arctichealth.org/en/permalink/ahliterature148105
Source
Can J Cardiol. 2009 Oct;25(10):567-79
Publication Type
Article
Date
Oct-2009
Author
Jacques Genest
Ruth McPherson
Jiri Frohlich
Todd Anderson
Norm Campbell
André Carpentier
Patrick Couture
Robert Dufour
George Fodor
Gordon A Francis
Steven Grover
Milan Gupta
Robert A Hegele
David C Lau
Lawrence Leiter
Gary F Lewis
Eva Lonn
G B John Mancini
Dominic Ng
Glen J Pearson
Allan Sniderman
James A Stone
Ehud Ur
Author Affiliation
McGill University Health Centre, Montreal, Canada. jacques.genest@muhc.mcgill.ca
Source
Can J Cardiol. 2009 Oct;25(10):567-79
Date
Oct-2009
Language
English
Publication Type
Article
Keywords
Adult
Canada
Cardiovascular Diseases - etiology - prevention & control
Congresses as topic
Diagnostic Techniques, Cardiovascular
Dyslipidemias - complications - diagnosis - drug therapy
Humans
Hypolipidemic Agents - therapeutic use
Practice Guidelines as Topic - standards
Risk Assessment - methods
Societies, Medical
Abstract
The present article represents the 2009 update of the Canadian Cardiovascular Society guidelines for the diagnosis and treatment of dyslipidemia and prevention of cardiovascular disease in the adult.
Notes
Cites: Lancet. 2005 Nov 26;366(9500):1849-6116310551
Cites: Am Heart J. 2005 Dec;150(6):1276-8116338271
Cites: CMAJ. 2006 Jan 17;174(2):156-716415457
Cites: J Intern Med. 2006 Mar;259(3):247-5816476102
Cites: Circulation. 2006 Mar 21;113(11):1406-1416534008
Cites: N Engl J Med. 2006 Apr 13;354(15):1567-7716531613
Cites: Circulation. 2006 May 16;113(19):2363-7216702489
Cites: Can J Cardiol. 2006 Sep;22(11):913-2716971976
Cites: Am J Med. 2006 Oct;119(10):812-917000207
Cites: Am J Cardiol. 2008 Apr 17;101(8A):58B-62B18375243
Cites: JAMA. 2008 Jun 4;299(21):2524-3218523221
Cites: Am J Cardiol. 2008 Jun 16;101(12A):51F-57F18549872
Cites: JAMA. 2008 Jul 9;300(2):197-20818612117
Cites: Circulation. 2008 Oct 21;118(17):1768-7518824640
Cites: Am J Cardiol. 2008 Nov 15;102(10):1312-718993147
Cites: Am J Cardiol. 2008 Nov 15;102(10):1341-718993152
Cites: N Engl J Med. 2008 Nov 20;359(21):2195-20718997196
Cites: Circulation. 2008 Nov 25;118(22):2243-51, 4p following 225118997194
Cites: N Engl J Med. 2008 Nov 27;359(22):2324-3619038879
Cites: Curr Opin Lipidol. 2006 Dec;17(6):619-2517095905
Cites: Nature. 2006 Dec 14;444(7121):881-717167477
Cites: Circulation. 2007 Jan 23;115(3):402-2617220398
Cites: JAMA. 2007 Jan 24;297(4):367-7917244833
Cites: JAMA. 2007 Feb 7;297(5):499-50817284700
Cites: JAMA. 2007 Feb 14;297(6):611-917299196
Cites: Int J Circumpolar Health. 2006 Dec;65(5):389-40217319084
Cites: Am J Gastroenterol. 2007 Mar;102(3):662-717156143
Cites: N Engl J Med. 2007 Apr 26;356(17):1723-3517460226
Cites: Ann Intern Med. 2007 May 1;146(9):640-817470832
Cites: N Engl J Med. 2007 Jun 7;356(23):2388-9817554120
Cites: Eur J Cardiovasc Prev Rehabil. 2007 Sep;14 Suppl 2:S1-11317726407
Cites: Circulation. 2007 Sep 11;116(11):1306-1717846344
Cites: Am J Cardiol. 2007 Oct 1;100(7):1047-5117884359
Cites: N Engl J Med. 2007 Sep 27;357(13):1301-1017898099
Cites: N Engl J Med. 2007 Nov 22;357(21):2109-2217984165
Cites: Arch Intern Med. 2007 Nov 26;167(21):2296-30318039987
Cites: N Engl J Med. 2007 Nov 29;357(22):2248-6117984166
Cites: Clin Gastroenterol Hepatol. 2008 Jan;6(1):41-518063423
Cites: J Am Soc Echocardiogr. 2008 Feb;21(2):93-111; quiz 189-9018261694
Cites: Circulation. 2008 Feb 12;117(6):743-5318212285
Cites: Am J Cardiol. 2008 Nov 17;102(10 Suppl):1K-34K19068318
Cites: Lancet. 2002 Jul 6;360(9326):7-2212114036
Cites: Circulation. 2003 Jan 28;107(3):391-712551861
Cites: Lancet. 2003 Apr 5;361(9364):1149-5812686036
Cites: N Engl J Med. 2003 Jul 31;349(5):465-7312890846
Cites: Arthritis Rheum. 2003 Sep;48(9):2519-2313130471
Cites: Circulation. 2003 Oct 28;108(17):2154-6914581387
Cites: N Engl J Med. 2004 Apr 8;350(15):1495-50415007110
Cites: JAMA. 2004 May 12;291(18):2204-1115138242
Cites: Lancet. 2004 Sep 11-17;364(9438):937-5215364185
Cites: N Engl J Med. 2004 Sep 23;351(13):1296-30515385656
Cites: N Engl J Med. 1987 Nov 12;317(20):1237-453313041
Cites: N Engl J Med. 1995 Nov 16;333(20):1301-77566020
Cites: Curr Opin Lipidol. 1995 Dec;6(6):386-88750253
Cites: Circulation. 1998 Jan 20;97(2):155-609445167
Cites: Lancet. 2008 Oct 4;372(9645):1231-918757089
Cites: Am J Cardiol. 2009 Feb 1;103(3):350-419166688
Cites: Clin Chem. 2009 Feb;55(2):378-8419106185
Cites: Curr Diab Rep. 2009 Feb;9(1):37-4219192423
Cites: N Engl J Med. 2009 Feb 26;360(9):859-7319246357
Cites: N Engl J Med. 2009 Apr 2;360(14):1395-40719332456
Cites: Lancet. 2009 Apr 4;373(9670):1175-8219329177
Cites: Ann Rheum Dis. 2009 Jul;68(7):1131-518697777
Cites: Circulation. 2000 Sep 5;102(10):1082-510973834
Cites: Lancet. 2000 Jul 22;356(9226):279-8411071182
Cites: JAMA. 1998 May 27;279(20):1615-229613910
Cites: Arthritis Rheum. 1999 Feb;42(2):338-4610025929
Cites: N Engl J Med. 1999 Aug 5;341(6):410-810438259
Cites: N Engl J Med. 2005 Apr 7;352(14):1425-3515755765
Cites: JAMA. 2005 Jul 20;294(3):326-3316030277
Cites: N Engl J Med. 2005 Jul 21;353(3):238-4816034009
Cites: Lancet. 2005 Sep 24-30;366(9491):1059-6216182882
Cites: Lancet. 2005 Oct 8;366(9493):1267-7816214597
Cites: JAMA. 2005 Nov 16;294(19):2437-4516287954
PubMed ID
19812802 View in PubMed
Less detail

2010 Canadian Hypertension Education Program recommendations: An annual update.

https://arctichealth.org/en/permalink/ahliterature142153
Source
Can Fam Physician. 2010 Jul;56(7):649-53
Publication Type
Article
Date
Jul-2010
Author
Norm Campbell
Margaret Moy Lum Kwong
Source
Can Fam Physician. 2010 Jul;56(7):649-53
Date
Jul-2010
Language
English
Publication Type
Article
Keywords
Canada
Diabetic Angiopathies - prevention & control - therapy
Education, Medical, Continuing
Guideline Adherence
Health promotion
Humans
Hypertension - prevention & control - therapy
Program Evaluation
Notes
Cites: Arch Intern Med. 2005 Jun 27;165(12):1410-915983291
Cites: Arch Intern Med. 2005 Jun 27;165(12):1401-915983290
Cites: Can J Cardiol. 2007 May 15;23(7):529-3817534459
Cites: Can J Cardiol. 2007 Dec;23(14):1124-3018060097
Cites: N Engl J Med. 2008 Apr 10;358(15):1547-5918378520
Cites: CMAJ. 2008 May 20;178(11):1441-918490640
Cites: CMAJ. 2008 May 20;178(11):1458-6018490641
Cites: Can J Cardiol. 2008 Jun;24(6):485-9018548146
Cites: Can J Cardiol. 2008 Jun;24(6):507-1218548150
Cites: Am J Hypertens. 2008 Nov;21(11):1210-518772857
Cites: J Am Coll Cardiol. 2008 Nov 25;52(22):1749-5719022154
Cites: N Engl J Med. 2008 Dec 4;359(23):2417-2819052124
Cites: Hypertension. 2009 Feb;53(2):128-3419114646
Cites: PLoS Med. 2009 Apr 28;6(4):e100005819399161
Cites: Can J Cardiol. 2009 May;25(5):279-8619417858
Cites: Can J Cardiol. 2009 May;25(5):287-9819417859
Cites: Can J Cardiol. 2009 May;25(5):299-30219417860
Cites: Eur Heart J. 2009 Jun;30(12):1434-919454575
Cites: J Hypertens. 2009 Jul;27(7):1472-719474763
Cites: Hypertension. 2009 Sep;54(3):475-8119620517
Cites: J Hypertens. 2006 Mar;24(3):423-3016467640
Cites: JAMA. 2002 Feb 27;287(8):1003-1011866648
Cites: JAMA. 2002 May 15;287(19):2542-5112020335
Cites: Can J Cardiol. 2002 Jun;18(6):657-6112107423
Cites: J Hypertens. 2004 Jan;22(1):11-915106785
Cites: Fam Pract. 1997 Apr;14(2):160-769137956
Cites: Blood Press. 1997 Nov;6(6):357-649495661
Cites: Am J Hypertens. 1998 Mar;11(3 Pt 2):57S-61S9546039
Cites: Lancet. 2005 Jan 15-21;365(9455):217-2315652604
Comment In: Can Fam Physician. 2010 Sep;56(9):86920841585
PubMed ID
20631271 View in PubMed
Less detail

2011 Canadian Hypertension Education Program recommendations: an annual update.

https://arctichealth.org/en/permalink/ahliterature128763
Source
Can Fam Physician. 2011 Dec;57(12):1393-7
Publication Type
Article
Date
Dec-2011
Author
Norm Campbell
Source
Can Fam Physician. 2011 Dec;57(12):1393-7
Date
Dec-2011
Language
English
Publication Type
Article
Keywords
Angiotensin Receptor Antagonists - therapeutic use
Canada
Diabetes Complications - complications
Diabetes Mellitus - drug therapy
Health education
Health Policy
Humans
Hypertension - complications - drug therapy - prevention & control
Life Style
Risk factors
Stroke - complications
Notes
Cites: Eur Heart J. 2001 Aug;22(15):1343-5211465967
Cites: Eur J Cardiovasc Prev Rehabil. 2010 Oct;17(5):519-2320195154
Cites: Stroke. 2002 May;33(5):1315-2011988609
Cites: Can J Cardiol. 2002 Jun;18(6):657-6112107423
Cites: J Hypertens. 2004 Jan;22(1):11-915106785
Cites: Arch Neurol. 1993 Aug;50(8):855-628352673
Cites: Fam Pract. 1997 Apr;14(2):160-769137956
Cites: Am J Hypertens. 1997 Oct;10(10 Pt 1):1097-1029370379
Cites: Arch Intern Med. 2005 Jun 27;165(12):1410-915983291
Cites: Can J Cardiol. 2007 May 1;23(6):437-4317487286
Cites: Can J Cardiol. 2007 May 15;23(7):529-3817534459
Cites: Arch Intern Med. 2007 Nov 26;167(21):2296-30318039987
Cites: Can J Cardiol. 2007 Dec;23(14):1124-3018060097
Cites: Circulation. 2008 Feb 12;117(6):743-5318212285
Cites: Lancet Neurol. 2008 May;7(5):391-918396107
Cites: Can J Cardiol. 2008 Jun;24(6):483-418548145
Cites: Can J Cardiol. 2008 Jun;24(6):485-9018548146
Cites: Can J Cardiol. 2008 Jun;24(6):497-118548148
Cites: Am J Hypertens. 2008 Nov;21(11):1210-518772857
Cites: Hypertension. 2009 Feb;53(2):128-3419114646
Cites: Can J Cardiol. 2009 May;25(5):279-8619417858
Cites: Can J Cardiol. 2009 May;25(5):299-30219417860
Cites: Eur Heart J. 2009 Jun;30(12):1434-919454575
Cites: J Hypertens. 2009 Jul;27(7):1472-719474763
Cites: Can J Cardiol. 2009 Aug;25(8):451-219668778
Cites: Arch Intern Med. 2009 Nov 23;169(21):1996-200219933962
Cites: Pharmacotherapy. 2010 Mar;30(3):228-3520180606
Cites: Health Rep. 2010 Mar;21(1):37-4620426225
Cites: N Engl J Med. 2010 Apr 29;362(17):1575-8520228401
Cites: Int J Stroke. 2010 Apr;5(2):110-620446945
Cites: Curr Opin Cardiol. 2010 Jul;25(4):366-7220502323
Cites: JAMA. 2002 Feb 27;287(8):1003-1011866648
PubMed ID
22170191 View in PubMed
Less detail

Calls for restricting the marketing of unhealthy food to children: Canadian cardiovascular health care and scientific community get ignored by policy makers. What can they do?

https://arctichealth.org/en/permalink/ahliterature104726
Source
Can J Cardiol. 2014 May;30(5):479-81
Publication Type
Article
Date
May-2014
Author
Norm Campbell
Andrew Pipe
Tara Duhaney
Author Affiliation
Department of Physiology and Pharmacology and Community Health Sciences, University of Calgary, Calgary, Alberta, Canada. Electronic address: ncampbel@ucalgary.ca.
Source
Can J Cardiol. 2014 May;30(5):479-81
Date
May-2014
Language
English
Publication Type
Article
Keywords
Canada
Cardiovascular Diseases - etiology - prevention & control - psychology
Child
Fast Foods - adverse effects
Food Habits
Food Industry - legislation & jurisprudence
Government Regulation
Health Policy
Humans
Marketing - legislation & jurisprudence
Societies, Medical - legislation & jurisprudence
PubMed ID
24630374 View in PubMed
Less detail

Changes in the rates of awareness, treatment and control of hypertension in Canada over the past two decades.

https://arctichealth.org/en/permalink/ahliterature134462
Source
CMAJ. 2011 Jun 14;183(9):1007-13
Publication Type
Article
Date
Jun-14-2011
Author
Finlay A McAlister
Kathryn Wilkins
Michel Joffres
Frans H H Leenen
George Fodor
Marianne Gee
Mark S Tremblay
Robin Walker
Helen Johansen
Norm Campbell
Author Affiliation
University of Alberta, Edmonton, Alberta. finlay.mcalister@ualberta.ca
Source
CMAJ. 2011 Jun 14;183(9):1007-13
Date
Jun-14-2011
Language
English
Publication Type
Article
Keywords
Adult
Aged
Antihypertensive Agents - therapeutic use
Blood Pressure - drug effects
Canada - epidemiology
Female
Humans
Hypertension - drug therapy - physiopathology
Male
Middle Aged
Prevalence
Young Adult
Abstract
Analyses of medication databases indicate marked increases in prescribing of antihypertensive drugs in Canada over the past decade. This study was done to examine the trends in the prevalence of hypertension and in control rates in Canada between 1992 and 2009.
Three population-based surveys, the 1986-1992 Canadian Heart Health Surveys, the 2006 Ontario Survey on the Prevalence and Control of Hypertension and the 2007-2009 Canadian Health Measures Survey, collected self-reported health information from, and measured blood pressure among, community-dwelling adults.
The population prevalence of hypertension was stable between 1992 and 2009 at 19.7%-21.6%. Hypertension control improved from 13.2% (95% confidence interval [CI] 10.7%-15.7%) in 1992 to 64.6% (95% CI 60.0%-69.2%) in 2009, reflecting improvements in awareness (from 56.9% [95% CI 53.1%-60.5%] in 1992 to 82.5% [95% CI 78.5%-86.0%] in 2009) and treatment (from 34.6% [95% CI 29.2%-40.0%] in 1992 to 79.0% [95% CI 71.3%-86.7%] in 2009) among people with hypertension. The size of improvements in awareness, treatment and control were similar among people who had or did not have cardiovascular comorbidities Although systolic blood pressures among patients with untreated hypertension were similar between 1992 and 2009 (ranging from 146 [95% CI 145-147] mm Hg to 148 [95% CI 144-151] mm Hg), people who did not have hypertension and patients with hypertension that was being treated showed substantially lower systolic pressures in 2009 than in 1992 (113 [95% CI 112-114] v. 117 [95% CI 117-117] mm Hg and 128 [95% CI 126-130] v. 145 [95% CI 143-147] mm Hg).
The prevalence of hypertension has remained stable among community-dwelling adults in Canada over the past two decades, but the rates for treatment and control of hypertension have improved markedly during this time.
Notes
Cites: N Engl J Med. 2010 Apr 29;362(17):1575-8520228401
Cites: Health Rep. 2010 Mar;21(1):37-4620426225
Cites: Hypertension. 2010 Oct;56(4):571-220696987
Cites: Lancet. 2011 Feb 12;377(9765):568-7721295844
Cites: JAMA. 2010 May 26;303(20):2043-5020501926
Cites: Arch Intern Med. 2000 Aug 14-28;160(15):2281-610927724
Cites: Arch Intern Med. 2002 Feb 25;162(4):413-2011863473
Cites: Lancet. 2002 Dec 14;360(9349):1903-1312493255
Cites: Am Heart J. 2003 May;145(5):888-9512766749
Cites: Eur Heart J. 2004 Mar;25(6):484-9115039128
Cites: J Hypertens. 2004 Jan;22(1):11-915106785
Cites: J Am Coll Cardiol. 2004 May 19;43(10):1738-4215145092
Cites: Stat Methods Med Res. 1996 Sep;5(3):283-3108931197
Cites: J Hum Hypertens. 1997 Jul;11(7):413-99283056
Cites: Am J Hypertens. 1997 Oct;10(10 Pt 1):1097-1029370379
Cites: J Hypertens. 1997 Mar;15(3):237-449468450
Cites: CMAJ. 1999 Sep 21;161(6):713-410513278
Cites: Hypertension. 2005 Jun;45(6):1113-815851629
Cites: Hypertension. 2006 Jan;47(1):22-816344380
Cites: J Hypertens. 2006 Mar;24(3):423-3016467640
Cites: Arch Intern Med. 2007 Jan 22;167(2):141-717242314
Cites: Can J Cardiol. 2007 May 1;23(6):437-4317487286
Cites: Am J Hypertens. 2008 Mar;21(3):280-318219304
Cites: CMAJ. 2008 May 20;178(11):1429-3518490638
Cites: CMAJ. 2008 May 20;178(11):1441-918490640
Cites: Clin Ther. 2008 Jun;30(6):1145-5418640470
Cites: Hypertension. 2009 Feb;53(2):128-3419114646
Cites: Hypertension. 2009 Apr;53(4):617-2319221214
Cites: J Hypertens. 2009 May;27(5):963-7519402221
Cites: BMJ. 2009;338:b166519454737
Cites: Eur Heart J. 2009 Jun;30(12):1434-919454575
Cites: Cardiovasc Diabetol. 2010;9:720122170
Cites: J Hum Hypertens. 2010 May;24(5):336-4419798089
Comment In: CMAJ. 2011 Jun 14;183(9):996-721576301
PubMed ID
21576297 View in PubMed
Less detail

The difference in hypertension control between older men and women.

https://arctichealth.org/en/permalink/ahliterature116835
Source
Health Rep. 2012 Dec;23(4):33-40
Publication Type
Article
Date
Dec-2012
Author
Kathryn Wilkins
Marianne Gee
Norm Campbell
Author Affiliation
Health Analysis Division, Statistics Canada, Ottawa, Ontario, K1A 0T6.
Source
Health Rep. 2012 Dec;23(4):33-40
Date
Dec-2012
Language
English
Publication Type
Article
Keywords
Age Factors
Aged
Antihypertensive Agents - therapeutic use
Blood Pressure Determination - methods
Canada - epidemiology
Confidence Intervals
Female
Health Surveys
Humans
Hypertension - drug therapy - epidemiology
Male
Middle Aged
Odds Ratio
Outcome Assessment (Health Care)
Population Surveillance
Prevalence
Sex Factors
Abstract
In Canada, as elsewhere, control of hypertension in older persons who are using antihypertensive medication is more likely in men than in women. The reasons for the observed difference are not known.
Data are from cycle 1 of the 2007 to 2009 Canadian Health Measures Survey (CHMS). The CHMS includes a comprehensive questionnaire, automated blood pressure (BP) measures, and a variety of biological and anthropometric assessments. Frequencies, means, cross-tabulations and multivariate models were produced to study differences between the sexes in hypertension control in a weighted sample representative of the household population aged 60 to 79.
The prevalence of hypertension was nearly equal among older men (60%) and women (59%), and the percentage of those with hypertension who were receiving pharmaceutical treatment was not statistically different (84% and 89%, respectively). However, despite current treatment, hypertension was uncontrolled in a substantially higher percentage of women (30%) than men (17%). The difference persisted when age, socio-economic status, co-morbidity, category of medication, anthropometry, and other correlates of hypertension were taken into account.
The factors considered in the analysis do not account for the advantage to older men in hypertension control. The findings underscore the importance of efforts to control blood pressure in older women.
PubMed ID
23356043 View in PubMed
Less detail

A framework for discussion on how to improve prevention, management, and control of hypertension in Canada.

https://arctichealth.org/en/permalink/ahliterature127541
Source
Can J Cardiol. 2012 May;28(3):262-9
Publication Type
Article
Date
May-2012
Author
Norm Campbell
Eric R Young
Denis Drouin
Barbara Legowski
Michael A Adams
Judi Farrell
Janusz Kaczorowski
Richard Lewanczuk
Margaret Moy Lum-Kwong
Sheldon Tobe
Author Affiliation
Department of Medicine, Libin Cardiovascular Institute of Alberta, University of Calgary, Calgary, Alberta, Canada. ncampbel@ucalgary.ca
Source
Can J Cardiol. 2012 May;28(3):262-9
Date
May-2012
Language
English
Publication Type
Article
Keywords
Adult
Aged
Antihypertensive Agents - therapeutic use
Blood Pressure Determination
Canada
Combined Modality Therapy
Diet
Disease Management
Evidence-Based Medicine - organization & administration
Exercise - physiology
Female
Health Education - organization & administration
Humans
Hypertension - epidemiology - prevention & control - therapy
Life Style
Male
Middle Aged
Practice Guidelines as Topic
Primary Prevention - organization & administration
Program Development
Program Evaluation
Public Health
Severity of Illness Index
Abstract
Increased blood pressure is a leading risk for premature death and disability. The causes of increased blood pressure are intuitive and well known. However, the fundamental basis and means for improving blood pressure control are highly integrated into our complex societal structure both inside and outside our health system and hence require a comprehensive discussion of the pathway forward. A group of Canadian experts was appointed by Hypertension Canada with funding from Public Health Agency of Canada and the Heart and Stroke Foundation of Canada, Canadian Institute for Health Research (HSFC-CIHR) Chair in Hypertension Prevention and Control to draft a discussion Framework for prevention and control of hypertension. The report includes an environmental scan of past and current activities, proposals for key indicators, and targets to be achieved by 2020, and what changes are likely to be required in Canada to achieve the proposed targets. The key targets are to reduce the prevalence of hypertension to 13% of adults and improve control to 78% of those with hypertension. Broad changes in government policy, research, and health services delivery are required for these changes to occur. The Hypertension Framework process is designed to have 3 phases. The first includes the experts' report which is summarized in this report. The second phase is to gather input and priorities for action from individuals and organizations for revision of the Framework. It is hoped the Framework will stimulate discussion and input for its full intended lifespan 2011-2020. The third phase is to work with individuals and organizations on the priorities set in phase 2.
PubMed ID
22284588 View in PubMed
Less detail
Source
CMAJ. 2008 Apr 22;178(9):1186-7
Publication Type
Article
Date
Apr-22-2008
Author
Norm Campbell
Source
CMAJ. 2008 Apr 22;178(9):1186-7
Date
Apr-22-2008
Language
English
Publication Type
Article
Keywords
Canada
Food Industry
Health education
Humans
Hypertension - prevention & control
Sodium, Dietary - administration & dosage
Notes
Cites: Can J Cardiol. 2007 May 1;23(6):437-4317487286
Cites: CMAJ. 2008 Feb 12;178(4):386-718202143
Comment On: CMAJ. 2008 Feb 12;178(4):386-718202143
PubMed ID
18427098 View in PubMed
Less detail

Home blood pressure monitoring among Canadian adults with hypertension: results from the 2009 Survey on Living with Chronic Diseases in Canada.

https://arctichealth.org/en/permalink/ahliterature143441
Source
Can J Cardiol. 2010 May;26(5):e152-7
Publication Type
Article
Date
May-2010
Author
Christina M Bancej
Norm Campbell
Donald W McKay
Marianne Nichol
Robin L Walker
Janusz Kaczorowski
Author Affiliation
Public Health Agency of Canada, Ottawa, Ontario.
Source
Can J Cardiol. 2010 May;26(5):e152-7
Date
May-2010
Language
English
Publication Type
Article
Keywords
Adult
Age Factors
Aged
Aged, 80 and over
Antihypertensive Agents - therapeutic use
Blood Pressure Determination - methods
Blood Pressure Monitoring, Ambulatory - methods - statistics & numerical data
Canada
Chronic Disease
Confidence Intervals
Cross-Sectional Studies
Female
Follow-Up Studies
Humans
Hypertension - diagnosis - drug therapy - epidemiology
Linear Models
Male
Middle Aged
Patient Compliance - statistics & numerical data
Patient Education as Topic
Probability
Questionnaires
Risk factors
Severity of Illness Index
Young Adult
Abstract
Canadians with hypertension are recommended to use home blood pressure monitoring (HBPM) on a regular basis.
To characterize the use of HBPM among Canadian adults with hypertension.
Respondents to the 2009 Survey on Living with Chronic Diseases in Canada who reported diagnosis of hypertension by a health professional (n=6142) were asked about blood pressure monitoring practices, sociodemographic characteristics, management of hypertension and blood pressure control.
Among Canadian adults with hypertension, 45.9% (95% CI 43.5% to 48.3%) monitor their own blood pressure at home, 29.7% (95% CI 41.1% to 46.3%) receive health professional instruction and 35.9% (95% CI 33.5% to 38.4%) share the results with their health professional. However, fewer than one in six Canadian adults diagnosed with hypertension monitor their own blood pressure at home regularly, with health professional instruction, and communicate results to a health professional. Regular HBPM was more likely among older adults (45 years of age and older); individuals who believed they had a plan for how to control their blood pressure; and those who had been shown how to perform HBPM by a health professional - with the latter factor most strongly associated with regular HBPM (prevalence rate ratio 2.8; 95% CI 2.4 to 3.4).
Although many Canadians with hypertension measure their blood pressure between health care professional visits, a minority do so according to current recommendations. More effective knowledge translation strategies are required to support self-management of hypertension through home measurement of blood pressure.
Notes
Cites: Ann Epidemiol. 2002 Oct;12(7):452-412377421
Cites: Health Rep. 2010 Mar;21(1):37-4620426225
Cites: Hypertens Res. 2003 Oct;26(10):771-8214621179
Cites: JAMA. 2004 Mar 17;291(11):1342-915026401
Cites: BMJ. 2004 Jul 17;329(7458):14515194600
Cites: Int J Epidemiol. 1994 Feb;23(1):201-38194918
Cites: Stat Methods Med Res. 1996 Sep;5(3):283-3108931197
Cites: Am J Hypertens. 1997 Apr;10(4 Pt 1):409-189128207
Cites: J Hypertens. 1998 Jun;16(6):725-319663911
Cites: J Hypertens. 1998 Jul;16(7):971-59794737
Cites: Kidney Int. 2006 Mar;69(5):900-616518349
Cites: Med Care. 2006 Jul;44(7):646-5716799359
Cites: Can J Cardiol. 2007 May 15;23(7):577-8017534466
Cites: J Hypertens. 2007 Sep;25(9):1751-6217762635
Cites: J Hypertens. 2008 Mar;26(3):446-5218300854
Cites: Can J Cardiol. 2008 Jun;24(6):485-9018548146
Cites: JAMA. 2008 Jun 25;299(24):2857-6718577730
Cites: J Clin Hypertens (Greenwich). 2008 Sep;10(9):692-918844764
Cites: J Hypertens. 2009 Jan;27(1):198-20319145785
Cites: Lancet. 2009 Mar 14;373(9667):876-819286071
Cites: Can J Cardiol. 2009 May;25(5):279-8619417858
Cites: J Hypertens. 2009 Jul;27(7):1472-719474763
Cites: Arch Intern Med. 2009 Oct 26;169(19):1748-5519858431
Cites: BMJ. 2002 Oct 26;325(7370):92512399340
PubMed ID
20485694 View in PubMed
Less detail

17 records – page 1 of 2.